Feb 21 • 21:30 UTC 🇨🇳 China South China Morning Post

Humans vs robots? China begs to disagree

China is increasingly embracing humanoid robots, integrating them into various aspects of daily life and entertainment, contrasting with other nations' caution.

In a bold demonstration of technological advancement, China showcased its growing acceptance of humanoid robots during the 2026 Spring Festival Gala, a major cultural event that attracted global attention. The gala featured humanoid robots skillfully performing martial arts and engaging in comedic sketches alongside human entertainers, highlighting a unique blend of technology and tradition that sets China apart in the global conversation about robotics. This spectacle reflects a broader trend in which China is not only leading in the production of robots but is also fostering a cultural acceptance of these machines as valuable collaborators in everyday life.

As the world grapples with concerns over AI and robotics—primarily fears surrounding job loss and ethical implications—China appears to be taking a different approach. Instead of viewing humanoid robots as threats, Chinese policymakers and businesses are actively promoting their integration across various sectors, from hospitality to public service. This represents a significant shift in perception, as the nation seeks to define its position in the global AI race, focusing on collaboration between humans and robots rather than conflict.

The implications of this acceptance are profound. By embracing humanoid robots, China aims to not only bolster its technological capabilities but also cultivate an image of innovation and modernity. This strategic move could position China as a leader in the global robotics market, where it could dictate the terms of engagement and development of humanoid technology. As other countries continue to debate the ethical and economic repercussions of integrating AI into society, China's commitment to robots may serve as a pivotal case study in redefining human-machine relations.

📡 Similar Coverage